ReviewLife (Basel, Switzerland)2025
Central Contrast Sensitivity as an Outcome Measure in Randomized Controlled Trials in Glaucoma-A Systematic Review.
Alexander Sverstad, Jens Riis Møller, Gianni Virgili, Augusto Azuara-Blanco, Josefine Freiberg, Simone Ahrensberg, Olav Kristianslund, Goran Petrovski, Miriam Kolko
Abstract readReview
In one paragraphReview in Life (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Alexander SverstadCenter for Eye Research and Innovative Diagnostics, Department of Ophthalmology, Oslo University Hospital and Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0450 Oslo, Norway.ORCID 0000-0002-1309-4830 Jens Riis MøllerDepartment of Drug Design and Pharmacology, University of Copenhagen, 2100 Copenhagen, Denmark.
Gianni VirgiliCentre for Public Health, Queen's University of Belfast, Belfast BT12 6BA, UK.
Augusto Azuara-BlancoCentre for Public Health, Queen's University of Belfast, Belfast BT12 6BA, UK.
Josefine FreibergDepartment of Drug Design and Pharmacology, University of Copenhagen, 2100 Copenhagen, Denmark.
Simone AhrensbergDepartment of Drug Design and Pharmacology, University of Copenhagen, 2100 Copenhagen, Denmark.
Olav KristianslundCenter for Eye Research and Innovative Diagnostics, Department of Ophthalmology, Oslo University Hospital and Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0450 Oslo, Norway.
Goran PetrovskiCenter for Eye Research and Innovative Diagnostics, Department of Ophthalmology, Oslo University Hospital and Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0450 Oslo, Norway.ORCID 0000-0003-2905-9252 Miriam KolkoDepartment of Drug Design and Pharmacology, University of Copenhagen, 2100 Copenhagen, Denmark.ORCID 0000-0001-8697-0734 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
central contrast sensitivitycontrast sensitivity testsglaucomaglaucoma diagnosisrandomized controlled trialssystematic review
Identifiers
PMID40724544
PMCPMC12299499
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390